Ibio, INC.

biotechnology & biomanufacturing company,developing therapeutics,vaccines and biomaterials

Based in TX

🤖

AI Overview

With $220K in lobbying spend across 9 quarterly filings, Ibio, INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2020 to 2022.

$220K
Total Spend
3
Years Active
1
Firms Hired
3
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$10K
2021$120K
2022$90K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Ibio, INC. disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATEHealth & Human Services, Dept of (HHS)Defense, Dept of (DOD)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED, Budget/Appropriations

Advance iBio as the leader in plant-made pharmaceutical manufacturing and collaboration between the U.S. Government for research and manufacturing including funding for facilitation of domestic vaccin

Specific focus on plant-made pharmaceutical manufacturing of vaccines, and therapies, and funding for research and direct manufacturing with the U.S. Government or other commercial partners.

FY22 funding for advanced manufacturing technologies that utilize agricultural cell line development.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.